Skip to main content
Clinical Trials/DRKS00022406
DRKS00022406
Completed
Not Applicable

Trial for collection of blood samples from healed Covid-19 patients - research and development of in-vitro diagnostics

R-Biopharm AG0 sites50 target enrollmentOctober 6, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
SARS-CoV-2 infectionCovid-19
Sponsor
R-Biopharm AG
Enrollment
50
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 6, 2020
End Date
December 16, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Ability to understand and sign the informed consent form
  • 2\. Women and men above 18 years old
  • 3\. Earlier Covid\-19 disease, confirmed by a positiv PCR result

Exclusion Criteria

  • 4\. Any event which in the opinion of the invesigator prevents the participation of this patient in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials